DRS insider sells 12,801 shares at $41.65 under 10b5-1 plan
Mark Dorfman, EVP, General Counsel and Secretary of Leonardo DRS (DRS), reported insider sales under a Rule 10b5-1 trading plan.
Rhea-AI Filing Summary
Mark Dorfman, EVP, General Counsel and Secretary of Leonardo DRS (DRS), reported insider sales under a Rule 10b5-1 trading plan. The Form 4 shows two dispositions on 09/12/2025: 4,267 shares and 8,534 shares sold at $41.65 per share, totaling 12,801 shares sold. The filing notes the trading plan was adopted on 06/13/2025. Following the reported transactions the form lists beneficial ownership positions of 47,734 shares and 39,200 shares as reported by the reporting person. The form was signed by attorney-in-fact Katherine Krebel on 09/15/2025.
Positive
- Disclosure of 10b5-1 plan adoption (06/13/2025) indicating pre-arranged, compliant trading
- Clear reporting of transaction details including dates, share counts, and price
Negative
- Insider sold 12,801 shares, which reduces the reporting person's shareholding
- No explanatory context provided about purpose of sales beyond 10b5-1 plan
Insights
TL;DR: Routine insider sales under a pre-established 10b5-1 plan indicate compliance but reduce the officer's stake.
The Form 4 documents planned sales executed under a Rule 10b5-1 plan adopted 06/13/2025, which supports compliance with insider-trading rules by placing trades on an automated schedule. The filing identifies Mark Dorfman as EVP, General Counsel and Secretary, and shows aggregated sales of 12,801 shares at $41.65 on 09/12/2025. The disclosure of the plan and execution date is standard governance practice and preserves transparency for investors and regulators. No additional governance concerns or amendments were disclosed in this filing.
TL;DR: The transactions are material only to the extent of share count sold; they appear routine and not a material corporate event.
The reported disposals total 12,801 shares executed at $41.65 per share on 09/12/2025 under a 10b5-1 plan. The filing reports post-transaction beneficial ownership figures of 47,734 and 39,200 shares as presented on separate reporting lines. There are no derivative transactions or additional amendments in this filing. Given the absence of other events or unusual disclosure, the sale appears to be a routine insider liquidity event rather than an operational or financial development affecting company fundamentals.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 4,267 | $41.65 | $178K |
| Sale | Common Stock | 8,534 | $41.65 | $355K |
Footnotes (1)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Mark Dorfman (DRS) report on Form 4?
When was the 10b5-1 trading plan adopted for these DRS transactions?
Who signed the Form 4 for Mark Dorfman (DRS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.